Clinical Trial Detail

NCT ID NCT02555189
Title Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Thomas Jefferson University
Indications

prostate cancer

Therapies

Ribociclib

Enzalutamide

Age Groups: adult

Additional content available in CKB BOOST